Secukinumab Ameliorates Oxidative Damage Induced by Subarachnoid Hemorrhage
World Neurosurgery · 2024
DOI: 10.1016/j.wneu.2024.07.080 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Neurosurgery, 2024. Verfasst von Veysel Kiyak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery-Tokat, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey. Electronic address: vyslkyk86@gmail.com. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Oxidative Stress, Rats, Wistar, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Tokat Gaziosmanpaşa University.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to investigate the histological and biochemical neuroprotective effects of secukinumab (SEC) on brain damage induced by subarachnoid hemorrhage (SAH) in male Wistar Albino rats. METHODS: Forty male Wistar Albino rats were randomly divided into 4 groups of equal size: control, SEC, SAH, and SAH + SEC. SAH was induced the SAH and SAH + SEC groups by injecting autologous blood collected from the hearts of the rats into the subarachnoid space via the foramen magnum. SEC was administered intraperitoneally once a week to the SEC and SAH + SEC groups after the surgical procedure. On the 14th day of surgery, the rats were sacrificed and their cerebral tissues were collected for biochemical analysis and histopathological examination. RESULTS: SAH led to changes in oxidative stress parameters by increasing malondialdehyde levels and decreasing superoxide dismutase, glutathione, catalase, and glutathione peroxidase levels. Histopathologically, cerebral tissues in the SAH groups showed alterations such as congestion and cell infiltration. Treatment with SEC significantly reduced malondialdehyde levels and increased superoxide dismutase, glutathione, catalase, and glutathione peroxidase levels. SEC also decreased histopathological alterations in brain tissues. CONCLUSIONS: This study revealed that SEC (3 mg/kg) therapeutically influenced oxidative and histopathological changes in blood parameters and brain tissues caused by experimental SAH. SEC helps reduce brain damage in rats with SAH and possesses antioxidant and neuroprotective properties. Further advanced studies are needed to prove its potential benefits for humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery-Tokat, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey. Electronic address: vyslkyk86@gmail.com.
- Department of Histology and Embryology-Tokat, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey.
- Department of Bioistatistic-Tokat, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey.
- Faculty of Medicine, Department of Biochemistry, Tokat Gaziosmanpasa University, Tokat, Turkey.
Förderung
- Tokat Gaziosmanpaşa University
Zitieren
APA
Kiyak, V., Gevrek, F., Demir, O., & Katar, M. (2024). Secukinumab Ameliorates Oxidative Damage Induced by Subarachnoid Hemorrhage. World Neurosurgery. https://doi.org/10.1016/j.wneu.2024.07.080
Vancouver
Kiyak V, Gevrek F, Demir O, Katar M. Secukinumab Ameliorates Oxidative Damage Induced by Subarachnoid Hemorrhage. World Neurosurgery. 2024. doi:10.1016/j.wneu.2024.07.080
BibTeX
@article{Kiyak2024,
author = {Kiyak, Veysel and Gevrek, Fikret and Demir, Osman and Katar, Muzaffer},
title = {Secukinumab Ameliorates Oxidative Damage Induced by Subarachnoid Hemorrhage},
journal = {World Neurosurgery},
year = {2024},
doi = {10.1016/j.wneu.2024.07.080}
}
EUVIMED